Synthesis and in vitro evaluation of tetrahydropyridines as potential CDK2 and DprE1 inhibitors

被引：0
|
作者：
Pravin R. Kharade
Uttam B. Chougale
Dipak S. Gaikwad
Satish S. Kadam
Kiran N. Patil
Sanket S. Rathod
Prafulla B. Choudhari
Savita S. Desai
机构：
[1] Department of Chemistry,Department of Chemistry
[2] Karmaveer Hire Arts,Department of Chemistry
[3] Science,Department of Pharmaceutical Chemistry
[4] Commerce and Education College,Research Laboratory in Heterocyclic Chemistry
[5] Vivekanand College (Autonomous),undefined
[6] Dr. Ghali College,undefined
[7] Bharati Vidyapeeth College of Pharmacy,undefined
[8] Devchand College,undefined
来源：
Research on Chemical Intermediates | 2024年 / 50卷
关键词：
Tetrahydropyridines; Ionic liquids; Molecular docking; DFT; ADMET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1777 / 1808
页数：31
相关论文
共 50 条
  • [1] Synthesis and in vitro evaluation of tetrahydropyridines as potential CDK2 and DprE1 inhibitors
    Kharade, Pravin R.
    Chougale, Uttam B.
    Gaikwad, Dipak S.
    Kadam, Satish S.
    Patil, Kiran N.
    Rathod, Sanket S.
    Choudhari, Prafulla B.
    Desai, Savita S.
    RESEARCH ON CHEMICAL INTERMEDIATES, 2024, 50 (04) : 1777 - 1808
  • [2] Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents
    Liu, Lingfeng
    Kong, Chengcheng
    Fumagalli, Marco
    Savkova, Karin
    Xu, Yiwen
    Huszar, Stanislav
    Sammartino, Jose C.
    Fan, Dongguang
    Chiarelli, Laurent R.
    Mikusova, Katarina
    Sun, Zhaogang
    Qiao, Chunhua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [3] In silico guided design of non-covalent inhibitors of DprE1: synthesis and biological evaluation
    Verma, H.
    Choudhary, S.
    Kumar, M.
    Silakari, O.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2021, 32 (04) : 333 - 352
  • [4] Identification of novel DprE1 inhibitors for the treatment of tuberculosis
    Franco, Jimmy
    Laverty, Daniel
    Daniels, Dave
    Wilsey, Claire
    Golijanin, Petar
    Gurka, Jessica
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [5] Discovery and evaluation of dual CDK1 and CDK2 inhibitors
    Payton, M
    Chung, G
    Yakowec, P
    Wong, A
    Powers, D
    Xiong, L
    Zhang, N
    Leal, J
    Bush, TL
    Santora, V
    Askew, B
    Tasker, A
    Radinsky, R
    Kendall, R
    Coats, S
    CANCER RESEARCH, 2006, 66 (08) : 4299 - 4308
  • [6] Design, Synthesis, and Molecular Docking of Novel Benzothiazinone Derivatives as DprE1 Inhibitors with Potential Antitubercular Activities
    Raghu, M. S.
    Jassim, Amar Yasser
    Kumar, K. Yogesh
    Alharethy, Fahd
    Prashanth, M. K.
    Jeon, Byong-Hun
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2025, 51 (01) : 65 - 78
  • [7] Synthesis and in vitro anticancer activity of some 2-oxindoline derivatives as potential CDK2 inhibitors
    Alshaye, Najla A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (24): : 15009 - 15022
  • [8] Synthetic molecules as DprE1 inhibitors: A patent review
    Imran, Mohd
    Alshrari, A. S.
    Thabet, Hamdy Kh.
    Abida
    Bakht, Md. Afroz
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (08) : 759 - 772
  • [9] e-Pharmacophore model-guided design of potential DprE1 inhibitors: synthesis, in vitro antitubercular assay and molecular modelling studies
    Kumar, Avinash
    Rajappan, Revathi
    Kini, Suvarna G.
    Rathi, Ekta
    Dharmarajan, Sriram
    Pai, K. Sreedhara Ranganath
    CHEMICAL PAPERS, 2021, 75 (10) : 5571 - 5585
  • [10] Designing and Synthesis of New Isatin Derivatives as Potential CDK2 Inhibitors
    Czelen, Przemyslaw
    Skotnicka, Agnieszka
    Szefler, Beata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
12345